172 related articles for article (PubMed ID: 8262049)
41. Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells.
Elefanty AG; Robb L; Birner R; Begley CG
Blood; 1997 Aug; 90(4):1435-47. PubMed ID: 9269761
[TBL] [Abstract][Full Text] [Related]
42. c-kit mRNA expression in human and murine hematopoietic cell lines.
André C; d'Auriol L; Lacombe C; Gisselbrecht S; Galibert F
Oncogene; 1989 Aug; 4(8):1047-9. PubMed ID: 2474787
[TBL] [Abstract][Full Text] [Related]
43. Genomic organization and regulation of the vav proto-oncogene.
Denkinger DJ; Borges CR; Butler CL; Cushman AM; Kawahara RS
Biochim Biophys Acta; 2000 Apr; 1491(1-3):253-62. PubMed ID: 10760587
[TBL] [Abstract][Full Text] [Related]
44. Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signaling.
Tedford K; Nitschke L; Girkontaite I; Charlesworth A; Chan G; Sakk V; Barbacid M; Fischer KD
Nat Immunol; 2001 Jun; 2(6):548-55. PubMed ID: 11376343
[TBL] [Abstract][Full Text] [Related]
45. Antisense myb inhibition of purified erythroid progenitors in development and differentiation is linked to cycling activity and expression of DNA polymerase alpha.
Valtieri M; Venturelli D; Caré A; Fossati C; Pelosi E; Labbaye C; Mattia G; Gewirtz AM; Calabretta B; Peschle C
Blood; 1991 Mar; 77(6):1181-90. PubMed ID: 1705831
[TBL] [Abstract][Full Text] [Related]
46. Vav: a potential link between tyrosine kinases and ras-like GTPases in hematopoietic cell signaling.
Hu P; Margolis B; Schlessinger J
Bioessays; 1993 Mar; 15(3):179-83. PubMed ID: 8489524
[TBL] [Abstract][Full Text] [Related]
47. Characterization of the promoter region of the human c-kit proto-oncogene.
Yamamoto K; Tojo A; Aoki N; Shibuya M
Jpn J Cancer Res; 1993 Nov; 84(11):1136-44. PubMed ID: 7506248
[TBL] [Abstract][Full Text] [Related]
48. The transcription factors c-myb and GATA-2 act independently in the regulation of normal hematopoiesis.
Melotti P; Calabretta B
Proc Natl Acad Sci U S A; 1996 May; 93(11):5313-8. PubMed ID: 8643572
[TBL] [Abstract][Full Text] [Related]
49. Granulocytic differentiation of normal hematopoietic precursor cells induced by transcription factor PU.1 correlates with negative regulation of the c-myb promoter.
Bellon T; Perrotti D; Calabretta B
Blood; 1997 Sep; 90(5):1828-39. PubMed ID: 9292515
[TBL] [Abstract][Full Text] [Related]
50. Thymus reconstitution by c-kit-expressing hematopoietic stem cells purified from adult mouse bone marrow.
de Vries P; Brasel KA; McKenna HJ; Williams DE; Watson JD
J Exp Med; 1992 Dec; 176(6):1503-9. PubMed ID: 1281208
[TBL] [Abstract][Full Text] [Related]
51. Role of the KIT protooncogene in normal and malignant human hematopoiesis.
Ratajczak MZ; Luger SM; DeRiel K; Abrahm J; Calabretta B; Gewirtz AM
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1710-4. PubMed ID: 1371882
[TBL] [Abstract][Full Text] [Related]
52. Expression of the vav oncogene in somatic cell hybrids.
Denkinger DJ; Kawahara RS
Exp Cell Res; 1997 May; 232(2):388-94. PubMed ID: 9168816
[TBL] [Abstract][Full Text] [Related]
53. Interaction of Vav with ENX-1, a putative transcriptional regulator of homeobox gene expression.
Hobert O; Jallal B; Ullrich A
Mol Cell Biol; 1996 Jun; 16(6):3066-73. PubMed ID: 8649418
[TBL] [Abstract][Full Text] [Related]
54. Zinc finger domains and phorbol ester pharmacophore. Analysis of binding to mutated form of protein kinase C zeta and the vav and c-raf proto-oncogene products.
Kazanietz MG; Bustelo XR; Barbacid M; Kolch W; Mischak H; Wong G; Pettit GR; Bruns JD; Blumberg PM
J Biol Chem; 1994 Apr; 269(15):11590-4. PubMed ID: 8157692
[TBL] [Abstract][Full Text] [Related]
55. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
[TBL] [Abstract][Full Text] [Related]
56. In vitro human embryonic stem cell hematopoiesis mimics MYB-independent yolk sac hematopoiesis.
Vanhee S; De Mulder K; Van Caeneghem Y; Verstichel G; Van Roy N; Menten B; Velghe I; Philippé J; De Bleser D; Lambrecht BN; Taghon T; Leclercq G; Kerre T; Vandekerckhove B
Haematologica; 2015 Feb; 100(2):157-66. PubMed ID: 25381126
[TBL] [Abstract][Full Text] [Related]
57. Sos, Vav, and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Grb2, Crk, and Crk-L adaptors.
Smit L; van der Horst G; Borst J
J Biol Chem; 1996 Apr; 271(15):8564-9. PubMed ID: 8621483
[TBL] [Abstract][Full Text] [Related]
58. Insulin-like growth factor-1 induces rapid tyrosine phosphorylation of the vav proto-oncogene product.
Uddin S; Yetter A; Katzav S; Hofmann C; White MF; Platanias LC
Exp Hematol; 1996 Apr; 24(5):622-7. PubMed ID: 8605967
[TBL] [Abstract][Full Text] [Related]
59. p95vav associates with the nuclear protein Ku-70.
Romero F; Dargemont C; Pozo F; Reeves WH; Camonis J; Gisselbrecht S; Fischer S
Mol Cell Biol; 1996 Jan; 16(1):37-44. PubMed ID: 8524317
[TBL] [Abstract][Full Text] [Related]
60. Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment.
Ogilvy S; Elefanty AG; Visvader J; Bath ML; Harris AW; Adams JM
Blood; 1998 Jan; 91(2):419-30. PubMed ID: 9427694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
